ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

First characterization of a Klebsiella pneumoniae clinical isolate producing VEB-1 and OXA-436 in Spain

Primera caracterización de un aislado clínico de Klebsiella pneumoniae productor de VEB-1 y OXA-436 en España

Laura Pastor Gómeza,

Corresponding author

lau_pasgom@hotmail.com

Corresponding author.

, Ana Isabel Aller Garcíaa, Inmaculada López-Hernándezb, Lorena López-Cererob,c,d

a Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen de Valme, Sevilla, Spain

b Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla IBIS, Sevilla, Spain

c Departamento de Microbiología, Universidad de Sevilla, Sevilla, Spain

d CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain

Read

147

Times
was read the article

Total PDF

115

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2024.07.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	95	31	126
2024 November	1	0	1
2024 September	4	1	5
2024 August	15	0	15

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Outpatient parenteral antibiotic therapy (OPAT)...

Enferm Infecc Microbiol Clin. 2024;42:581-7

Corrigendum a: Ecografía clínica:...

Enferm Infecc Microbiol Clin. 2024;42:281

The current status of arboviruses with major...

Enferm Infecc Microbiol Clin. 2024;42:516-26

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter